[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343788-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-343788-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","a-developmental-biliary-lineage-program-cooperates-with-wnt-activation-to-promote-cell-proliferation-in-hepatoblastoma","A developmental biliary lineage program cooperates with Wnt activation to promote cell proliferation in hepatoblastoma","","Cancers evolve not only via clonal somatic mutations but also through epigenetic mechanisms that reshape cell phenotype. Using histology-guided approaches and spatial transcriptomics, the study characterizes hepatoblastoma and reveals substantial histologic and proliferative heterogeneity despite Wnt/β-catenin pathway activating mutations. Highly proliferative embryonal regions express Wnt targets, the biliary factor SOX4, and focal FGF19, where Wnt activation makes FGF19 a required paracrine growth signal, supporting tumor cell proliferation.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-developmental-biliary-lineage-program-cooperates-with-wnt-activation-to-promote-cell-proliferation-in-hepatoblastoma/343788/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-developmental-biliary-lineage-program-cooperates-with-wnt-activation-to-promote-cell-proliferation-in-hepatoblastoma/343788.png","ImageObject",300,407,{"name":42,"@type":43},"Eden","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"How do cancers develop heterogeneity according to this article?","Question",{"text":62,"@type":63},"The article describes heterogeneity arising through both clonal somatic mutations and epigenetic mechanisms that alter cell phenotype.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"What role does the Wnt/β-catenin pathway play in hepatoblastoma here?",{"text":67,"@type":63},"It notes that many hepatoblastomas carry CTNNB1 mutations that constitutively activate Wnt/β-catenin signaling, and highly proliferative regions show high Wnt target gene expression.",{"name":69,"@type":60,"acceptedAnswer":70},"Why is FGF19 important in Wnt-activated hepatoblastoma tumor models?",{"text":71,"@type":63},"In patient-derived tumor organoids with constitutive Wnt activation, FGF19 is identified as a required growth signal for FGF19-negative cells, acting as a paracrine proliferative cue.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},343788,1790173970,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","| |  |  | |\n| --- | --- | --- | --- |\n| Article [https://doi.org/10.1038/s41467-024-53802-4](https://doi.org/10.1038/s41467-024-53802-4) |  |  |  |\n| A developmental biliary lineage program cooperates with Wnt activation to promote cell proliferation in hepatoblastoma |  |  |  |\n| Received: 17 July 2023\u003Cbr>Accepted: 17 October 2024 Check for updates | Peng V. Wu 1,2,3,4,8,9 , Matt Fish1,2,3, Florette K. Hazard5,10, Chunfang Zhu5, Sujay Vennam5, Hannah Walton1,2,3,11, Dhananjay Wagh6, John Coller6, Joanna Przybyl5,12,13, Maurizio Morri7,14, Norma Neff 7, Robert B. West5 & Roel Nusse 1,2,3 \u003Cbr>Cancers evolve not only through the acquisition and clonal transmission of somatic mutations but also by epigenetic mechanisms that modify cell phenotype. Here, we use histology-guided and spatial transcriptomics to characterize hepatoblastoma, a childhood liver cancer that exhibits signiﬁcant histologic and proliferative heterogeneity despite clonal activating mutations in the Wnt/β -catenin pathway. Highly proliferative regions with embryonal histology show high expression of Wnt target genes, the embryonic biliary transcription factor SOX4, and striking focal expression of the growth factor FGF19. In patientderived tumoroids with constitutive Wnt activation, FGF19 is a required growth signal for FGF19-negative cells. Indeed, some tumoroids contain subsets of cells that endogenously express FGF19, downstream ofWnt/β-catenin and SOX4. Thus, the embryonic biliary lineage program cooperates with stabilized nuclear β-catenin, inducing FGF19 as a paracrine growth signal that promotes tumor cell proliferation, together with active Wnt signaling. In this pediatric cancer presumed to originate from a multipotent hepatobiliary progenitor, lineage-driven heterogeneity results in a functional growth advantage, a non-genetic mechanism whereby developmental lineage programs inﬂuence tumor evolution. |  |  |\n| Cancers are classically thought to develop through clonal evolution, whereby sequential somatic mutations give rise to heterogeneous cell lineages subject to selective forces, leading to the emergence of subclones1,2. On the other hand, epigenetic mechanisms, which |  | generate the vast heterogeneity of cells and tissues arising during normal embryogenesis, can signiﬁcantly expand the diversity of cells carrying the same genetic mutations3–5. Such paths toward intratumoral heterogeneity may be particularly relevant for pediatric |  |\n\n1Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305, USA. 2Department of Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305, USA. 3Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA94305, USA. 4Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA. 5Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA. 6Stanford Genomics, Stanford University, Stanford, CA 94305, USA. 7Chan Zuckerberg Biohub, Stanford, CA 94305, USA. 8Present address: Division of Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA. 9Present address: Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA. 10Present address: Department of Pathology and Laboratory Medicine, University of California Davis School of Medicine, Sacramento, CA 95817, USA. 11Present address: Department of Population Health, NYC Health + Hospitals, New York, NY 10004, USA. 12Present address: Department of Surgery, McGill University, Montreal H4A 3J1 QC, Canada. 13Present address: Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal H4A 3J1 QC, Canada. 14Present address: Altos Labs, Redwood City, CA 94065, USA. e-mail: [Peng.Wu@cchmc.org](Peng.Wu@cchmc.org); [rnusse@stanford.edu](rnusse@stanford.edu)  \ncancers with embryonic origins and relatively lower mutat","cbCaim9FOwcO1ShT","https://ap.wps.com/l/cbCaim9FOwcO1ShT","pdf",4901107,"English","# Abstract\n## Background and rationale\n## Study approach\n## Key findings","[{\"question\":\"How do cancers develop heterogeneity according to this article?\",\"answer\":\"The article describes heterogeneity arising through both clonal somatic mutations and epigenetic mechanisms that alter cell phenotype.\"},{\"question\":\"What role does the Wnt/β-catenin pathway play in hepatoblastoma here?\",\"answer\":\"It notes that many hepatoblastomas carry CTNNB1 mutations that constitutively activate Wnt/β-catenin signaling, and highly proliferative regions show high Wnt target gene expression.\"},{\"question\":\"Why is FGF19 important in Wnt-activated hepatoblastoma tumor models?\",\"answer\":\"In patient-derived tumor organoids with constitutive Wnt activation, FGF19 is identified as a required growth signal for FGF19-negative cells, acting as a paracrine proliferative cue.\"}]","A developmental biliary lineage program cooperates with Wnt activation to promote cell proliferation in hepatoblastoma | PDF",1790052115,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14debfb3ff1970837f411dbd54b2de96.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd9314e3002ced38ea418814761c5574.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/182e8419e56c18cbe8a473f0e9013577.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ffa97a3e777707f3d7264121f8626f9.webp",980,1301]